Skip to content

VHCP Management III, LLC

Follow

13F filer, CIK 1738053, New York, NY

VHCP Management III, LLC reported $214,180,000 across 17 holdings for the quarter ended 2019-06-30, in a 13F-HR filed 2019-08-13. Its ten largest share positions make up 93.72% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000950123-19-007812

Period
2019-06-30
Reported value
$214M
Holdings
17
Top 10 weight
93.72%
New
1
Sold out
0

Stakes and trades reported after 2019-06-30

13D, 13G and Form 4 filings by this filer's group, dated after the 13F period, on securities the quarter does not hold as shares.

  • OKUR ONKURE THERAPEUTICS INC: 13G 2,309,559 shares, 5.7% of the class, 13G filed 2026-11-20, 0001231919-26-001621Timeline
    Accepted , ingested
  • ENTX ENTERA BIO LTD: 13G 8,861,763 shares, 5.1% of the class, 13G filed 2026-10-30, 0001738048-26-000079Timeline
    Accepted , ingested
  • LYCA LYCIA THERAPEUTICS INC: 13G 6,850,237 shares, 11.9% of the class, 13G filed 2026-10-30, 0001738048-26-000077Timeline
    Accepted , ingested
  • FLSC FRAZIER LIFE SCIENCES ACQ-A: 13G 700,000 shares, 9% of the class, 13G filed 2026-10-27, 0001738048-26-000075Timeline
    Accepted , ingested
  • XFOR X4 PHARMACEUTICALS INC: 13G/A 7,644,072 shares, 7.6% of the class, 13G/A filed 2026-11-16, 0001738048-26-000100Timeline
    Accepted , ingested
  • VOR VOR BIOPHARMA INC: 13G/A 6,443,619 shares, 9.9% of the class, 13G/A filed 2026-11-16, 0001738048-26-000098Timeline
    Accepted , ingested
  • KRRO KORRO BIO INC: 13G/A 1,474,162 shares, 9.9% of the class, 13G/A filed 2026-11-16, 0001738048-26-000096Timeline
    Accepted , ingested
  • JBIO JADE BIOSCIENCES INC: 13G/A 3,858,984 shares, 5.9% of the class, 13G/A filed 2026-11-16, 0001738048-26-000094Timeline
    Accepted , ingested
  • HELP HELUS PHARMA INC: 13G/A 2,688,175 shares, 3.5% of the class, 13G/A filed 2026-11-16, 0001738048-26-000092Timeline
    Accepted , ingested
  • CBIO CRESCENT BIOPHARMA INC.: 13G/A 2,228,641 shares, 5.9% of the class, 13G/A filed 2026-11-16, 0001738048-26-000090Timeline
    Accepted , ingested
  • ACHV ACHIEVE LIFE SCIENCE INC: 13G/A 5,502,064 shares, 5.2% of the class, 13G/A filed 2026-11-16, 0001738048-26-000088Timeline
    Accepted , ingested

Largest buys vs the previous quarter

SecurityShares changeApprox. value
MISTnew+2,066,529$56.1M
AXSMadded+543,285$14M
PTGXadded+263,025$3.19M
LA JOLLA PHARMACEUTICAL COadded+248,298$2.3M
RA PHARMACEUTICALS INCadded+75,637$2.27M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
TRICIDA INCreduced-360,839-$14.2M
KALVreduced-332,746-$7.37M
KADMON HOLDINGS INCreduced-965,733-$1.99M
ORCHARD THERAPEUTICS PLCreduced-134,778-$1.89M
BCRXreduced-352,884-$1.34M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q2 2019

Share positions as resolved from 13F-HR 0000950123-19-007812, largest first. % of portfolio is the value over $214,180,000, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
MISTMILESTONE PHARMACEUTICALS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: not loaded; 2018Q2: not loaded; 2018Q3: not reported; 2018Q4: not reported; 2019Q1: not reported; 2019Q2: 2,066,529 shares 2,066,529$56.1M26.2%newTimeline
AXSMAXSOME THERAPEUTICS INC.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: not loaded; 2018Q2: not loaded; 2018Q3: not reported; 2018Q4: not reported; 2019Q1: 1,068,044 shares; 2019Q2: 1,611,329 shares 1,611,329$41.5M19.37%+543,285Timeline
RA PHARMACEUTICALS INCRA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: not loaded; 2018Q2: not loaded; 2018Q3: not reported; 2018Q4: 594,713 shares; 2019Q1: 594,713 shares; 2019Q2: 670,350 shares 670,350$20.2M9.41%+75,637
KALVKALVISTA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: not loaded; 2018Q2: not loaded; 2018Q3: 1,284,931 shares; 2018Q4: 1,284,931 shares; 2019Q1: 970,630 shares; 2019Q2: 637,884 shares 637,884$14.1M6.6%-332,746Timeline
ObsEva SAObsEva SAQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: not loaded; 2018Q2: not loaded; 2018Q3: 1,159,789 shares; 2018Q4: 1,159,789 shares; 2019Q1: 1,159,789 shares; 2019Q2: 1,159,789 shares 1,159,789$13.1M6.12%0
PTGXPROTAGONIST THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: not loaded; 2018Q2: not loaded; 2018Q3: not reported; 2018Q4: 423,176 shares; 2019Q1: 809,323 shares; 2019Q2: 1,072,348 shares 1,072,348$13M6.06%+263,025Timeline
LA JOLLA PHARMACEUTICAL COLA JOLLA PHARMACEUTICAL COQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: not loaded; 2018Q2: not loaded; 2018Q3: not reported; 2018Q4: not reported; 2019Q1: 1,003,600 shares; 2019Q2: 1,251,898 shares 1,251,898$11.6M5.41%+248,298
TRICIDA INCTRICIDA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: not loaded; 2018Q2: not loaded; 2018Q3: 650,585 shares; 2018Q4: 650,585 shares; 2019Q1: 650,585 shares; 2019Q2: 289,746 shares 289,746$11.4M5.34%-360,839
BCRXBIOCRYST PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: not loaded; 2018Q2: not loaded; 2018Q3: 3,061,091 shares; 2018Q4: 3,061,091 shares; 2019Q1: 3,061,091 shares; 2019Q2: 2,708,207 shares 2,708,207$10.3M4.79%-352,884Timeline
ORCHARD THERAPEUTICS PLCORCHARD THERAPEUTICS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: not loaded; 2018Q2: not loaded; 2018Q3: not reported; 2018Q4: 1,041,515 shares; 2019Q1: 811,030 shares; 2019Q2: 676,252 shares 676,252$9.46M4.42%-134,778
MARINUS PHARMACEUTICALS INCMARINUS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: not loaded; 2018Q2: not loaded; 2018Q3: 672,271 shares; 2018Q4: 1,258,964 shares; 2019Q1: 1,258,964 shares; 2019Q2: 1,258,964 shares 1,258,964$5.22M2.44%0
KINIKSA PHARMACEUTICALS LTDKINIKSA PHARMACEUTICALS LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: not loaded; 2018Q2: not loaded; 2018Q3: 327,777 shares; 2018Q4: 327,777 shares; 2019Q1: 327,777 shares; 2019Q2: 312,320 shares 312,320$4.23M1.97%-15,457
BELLEROPHON THERAPEUTICS INCBELLEROPHON THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: not loaded; 2018Q2: not loaded; 2018Q3: 2,274,370 shares; 2018Q4: 2,274,370 shares; 2019Q1: 2,417,227 shares; 2019Q2: 2,417,227 shares 2,417,227$1.45M0.68%0
KADMON HOLDINGS INCKADMON HOLDINGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: not loaded; 2018Q2: not loaded; 2018Q3: 2,388,572 shares; 2018Q4: 2,388,572 shares; 2019Q1: 1,387,874 shares; 2019Q2: 422,141 shares 422,141$870K0.41%-965,733
CONSTELLATION PHARMACEUTICALCONSTELLATION PHARMACEUTICALQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: not loaded; 2018Q2: not loaded; 2018Q3: 66,667 shares; 2018Q4: 66,667 shares; 2019Q1: 66,667 shares; 2019Q2: 66,667 shares 66,667$819K0.38%0
GEMPHIRE THERAPEUTICS INCGEMPHIRE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: not loaded; 2018Q2: not loaded; 2018Q3: 869,538 shares; 2018Q4: 869,538 shares; 2019Q1: 869,538 shares; 2019Q2: 798,066 shares 798,066$646K0.3%-71,472
YUMANITY THERAPEUTICS INCYUMANITY THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: not loaded; 2018Q2: not loaded; 2018Q3: not reported; 2018Q4: 848,610 shares; 2019Q1: 722,890 shares; 2019Q2: 221,267 shares 221,267$216K0.1%-501,623

How Q2 2019 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0000950123-19-007812 base2019-08-13acceptance time not in the bulk data set